COPD Assessment Test Can Predict Depression
Recruitment status was Not yet recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The frequency of depression in COPD patients are substantial and early detection and prevention of depression is critical.
Recently, COPD assessment test (CAT) was developed and validated to assess the impact of COPD on patients' quality of life.
In this prospective study, we will investigate the predictive utility of CAT for predicting depression in COPD patients.
| Condition |
|---|
|
Depression, COPD |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Cross-Sectional |
| Official Title: | COPD Assessment Test Can Predict Depression |
- The predictive utility of the COPD assessment test (CAT) scores for predicting depression in COPD patients [ Time Frame: 1 year ] [ Designated as safety issue: No ]The association of CAT with depression score
| Estimated Enrollment: | 600 |
| Study Start Date: | December 2012 |
| Estimated Study Completion Date: | May 2013 |
| Estimated Primary Completion Date: | February 2013 (Final data collection date for primary outcome measure) |
This study is aimed to investigate the association between the COPD Assessment Test (CAT) and depression in stable COPD patients. Stable COPD patients will be enrolled from the tertiary hospitals. All patients will undergo lung function tests. The Korean versions of the CAT (COPD assessment test) and Patient Health Questionnaire-9 (PHQ-9) will be used to assess COPD symptoms and depressive disorder, respectively.
We will compare the depresssion frequency among GOLD classifications of airway limitation and among the four CAT groups. And. we will also investigate which items of the CAT are the strongest indicators of depression.
Eligibility| Ages Eligible for Study: | 40 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Stable COPD patients who visit outpatient departments.
Inclusion Criteria:
- COPD patients who aged > or = 40 years
Exclusion Criteria:
- acute exacerbation within 3 months
- bronchial asthma or an increase in FEV1 of more than 12% of the predicted value with the use of 400 µg of albuterol.
- other lung diseases such as bronchiectasis, interstitial lung disease, and tuberculosis-destroyed lungs.
- who denied to consent.
Contacts and Locations| Contact: Sunghoon Park, Dr. | 82-31-380-3803 | f2000tj@gmail.com |
| Korea, Republic of | |
| Hallym University Sacred Heart Hospital, Department of Pulmonary, Critical Care Medicine | Not yet recruiting |
| Anyang-, Gyeonggi-do, Korea, Republic of, 431-070 | |
| Contact: Sunghoon Park, MD 82-31-380-3803 f2000tj@gmail.com | |
| Contact: Sun Hyang Kim 82-31-380-1975 tjsgid625@naver.com | |
| Principal Investigator: | KI-Suck Jung, Dr. | Hallym University Medical Center |
More Information
No publications provided
| Responsible Party: | Hallym University Medical Center |
| ClinicalTrials.gov Identifier: | NCT01727219 History of Changes |
| Other Study ID Numbers: | 2011-I010 |
| Study First Received: | November 12, 2012 |
| Last Updated: | November 18, 2012 |
| Health Authority: | Korea: Ministry for Health, Welfare and Family Affairs |
Additional relevant MeSH terms:
|
Depression Depressive Disorder Pulmonary Disease, Chronic Obstructive Behavioral Symptoms Mood Disorders |
Mental Disorders Lung Diseases, Obstructive Lung Diseases Respiratory Tract Diseases |
ClinicalTrials.gov processed this record on May 22, 2013